Literature DB >> 19805667

Time to treatment does not influence overall survival in newly diagnosed mantle-cell lymphoma.

Heather E Eve, Michelle V Furtado, Michael D Hamon, Simon A J Rule.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19805667     DOI： 10.1200/JCO.2009.23.9731

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  18 in total

Review 1.  Current approaches and advance in mantle cell lymphoma treatment.

Authors:  Yao Liu; Xi Zhang; Jiang-Fan Zhong
Journal:  Stem Cell Investig       Date:  2015-09-29

2.  Proapoptotic protein BIM as a novel prognostic marker in mantle cell lymphoma.

Authors:  Jeff D Wang; Samuel G Katz; Elizabeth A Morgan; David T Yang; Xueliang Pan; Mina L Xu
Journal:  Hum Pathol       Date:  2019-08-16       Impact factor: 3.466

Review 3.  Mantle cell lymphoma: observation to transplantation.

Authors:  Babak Rajabi; John W Sweetenham
Journal:  Ther Adv Hematol       Date:  2015-02

4.  Autoimmune haemolytic anaemia associated with mantle cell lymphoma.

Authors:  Heather E Eve; Simon A J Rule
Journal:  Int J Hematol       Date:  2010-03       Impact factor: 2.490

5.  Indolent mantle cell lymphoma.

Authors:  Michelle Furtado; Simon Rule
Journal:  Haematologica       Date:  2011-08       Impact factor: 9.941

6.  Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease.

Authors:  C Royo; A Navarro; G Clot; I Salaverria; E Giné; P Jares; D Colomer; A Wiestner; W H Wilson; M C Vegliante; V Fernandez; E M Hartmann; N Trim; W N Erber; S H Swerdlow; W Klapper; M J S Dyer; M Vargas-Pabón; G Ott; A Rosenwald; R Siebert; A López-Guillermo; E Campo; S Beà
Journal:  Leukemia       Date:  2012-03-19       Impact factor: 11.528

Review 7.  Mantle cell lymphoma--a spectrum from indolent to aggressive disease.

Authors:  Birgitta Sander; Leticia Quintanilla-Martinez; German Ott; Luc Xerri; Isinsu Kuzu; John K C Chan; Steven H Swerdlow; Elias Campo
Journal:  Virchows Arch       Date:  2015-08-23       Impact factor: 4.064

8.  Mantle cell lymphoma: taking therapeutic advantage of new insights into the biology.

Authors:  Tiffany Tang; Peter Martin
Journal:  Curr Hematol Malig Rep       Date:  2014-09       Impact factor: 3.952

9.  Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry.

Authors:  Blanca Espinet; Ana Ferrer; Beatriz Bellosillo; Lara Nonell; Antonio Salar; Concepción Fernández-Rodríguez; Eulàlia Puigdecanet; Javier Gimeno; Mar Garcia-Garcia; Maria Carmen Vela; Elisa Luño; Rosa Collado; José Tomás Navarro; Esmeralda de la Banda; Pau Abrisqueta; Leonor Arenillas; Cristina Serrano; Josep Lloreta; Belén Miñana; Andrea Cerutti; Lourdes Florensa; Alberto Orfao; Ferran Sanz; Francesc Solé; David Dominguez-Sola; Sergio Serrano
Journal:  Clin Cancer Res       Date:  2013-12-18       Impact factor: 12.531

10.  In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior.

Authors:  Alejandra Carvajal-Cuenca; Luz F Sua; Nhora M Silva; Stefania Pittaluga; Cristina Royo; Joo Y Song; Rachel L Sargent; Blanca Espinet; Fina Climent; Samuel A Jacobs; Jan Delabie; Kikkeri N Naresh; Adam Bagg; Pierre Brousset; Roger A Warnke; Sergi Serrano; Nancy Lee Harris; Steven H Swerdlow; Elaine S Jaffe; Elías Campo
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.